Qual é o preço para IntelGenx Technologies Corp. (IGX)

O preço para IntelGenx Technologies Corp. (IGX) é $0.17446996

Qual é a capitalização de mercado para IntelGenx Technologies Corp. (IGX)

A capitalização de mercado para IntelGenx Technologies Corp. (IGX) é $26.97M

Lucros de IntelGenx Technologies Corp. (IGX)

IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.

Ano	Lucros	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Lucros

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Lucros	Diferença de Lucros	País
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Moderna, Inc. MRNA.US	$-3.09B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$1.61B	-	AU
Lonza Group AG LONN.SW	-	-	CH

Empresa

Lucros

Diferença de Lucros

País